Tardive Dyskinesia (TD) is a hyperkinetic movement disorder caused by chronic treatment of psychiatric patients with dopamine (DA) receptor blocking drugs (Stacy & Jankovic 1991). Although TD is one of the most important and frequently encountered iatrogenic disorders in clinical medicine, its pathophysiology is poorly understood.We have observed a hyperkinetic movement disorder in rats experimentally infected with a neurotropic RNA virus, Borna disease virus, that may provide important insights into the pathophysiology of TD. Like TD patients, infected rats show prominent orofacial dyskinesias. In keeping with the dopamine (Goetz & Klawans 1982) and anatomic (Fibiger & Lloyd 1984) hypotheses of TD, the Borna disease rat model shows enhanced behavioural sensitivity to DA agonists and selective striatal cell damage.There is also evidence of DA deafferentation and heterogeneous reduction of D2 binding in the caudate-putamen, particularly from sites implicated in oral behaviour. These observations on a virus-induced movement disorder offer novel approaches to TD pathogenesis.
Introduction
Borna disease virus (BDV) is an RNA virus that causes a progressive central nervous system (CNS) disorder in immunocompetent animals (Borna disease, BD) (Ludwig et al. 1988) . The virus has worldwide distribution and naturally infects a wide variety of vertebrate hosts including horses, sheep, cattle, cats and domestic fowl (Lipkin & Koprowski 1995) . Primates, such as tree shrews and rhesus monkeys, are susceptible to experimental disease (Sprankel et al. 1978 , Stitz et al. 1980 ). An increased prevalence of antibodies reactive with BDV proteins has been reported in subjects with neuropsychiatric disorders, suggesting the possibility that BDV or a related virus may cause human disease (Rott et al. 1985 , Fu et al. 1993 .
BDV is a novel infectious agent. The negative-sense RNA genome was recently cloned to reveal only limited similarities in sequence and organization to other viruses (Briese et al. 1994 , Cubitt et al. 1994 . In vivo and in vitro, BDV establishes persistent neuronal and glial infections. Important as a virus with unique biology and as a potential human pathogen, BDV can now be linked to another condition of monoamine transmitter imbalance, a dyskinetic movement disorder.
Methods

Infection of animals
Under metofane anaesthesia, 1-month-old male Lewis rats (Charles River Labs, Wilmington, MA, USA) were inoculated intracerebrally (i.c.) into right lateral ventricle with either 1.6×10 4 tissue culture infectious dose units of BDV (BD rats), or phosphate buffered saline (PBS, normal control, NL rats) in a total volume of 30 µL.Virus stock was a 10% wt/vol BD rat brain homogenate in PBS (Carbone et al. 1987) . Infection was confirmed by the appearance of a clinical syndrome consistent with BD and the presence of antibodies reactive with viral proteins by Western blot. Animals were tested or killed 45 days after i.c. inoculation with either virus or PBS.
